British rules outlaw disguised promotion of drugs

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7006.692a (Published 09 September 1995) Cite this as: BMJ 1995;311:692
  1. Frank Wells
  1. Director Department of Medicine, Science, and Technology, Association of the British Pharmaceutical Industry, London SW1A 2DY

    EDITOR,—The articles debating financial ties as part of informed consent to postmarketing research1 omit to mention that, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial